Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
View in:
PubMed
subject areas
Adolescent
Adult
Anemia, Sickle Cell
Antisickling Agents
Benzaldehydes
Biomarkers
Child
Dose-Response Relationship, Drug
Double-Blind Method
Drug Therapy, Combination
Female
Hemoglobin, Sickle
Hemoglobins
Hemolysis
Humans
Hydroxyurea
Intention to Treat Analysis
Male
Middle Aged
Polymerization
Pyrazines
Pyrazoles
Young Adult
authors with profiles
Miguel Raul Abboud